Clinical characteristics of patients with multiple system atrophy in Singapore

Annals of the Academy of Medicine Singapore

Volumn 34, Issue 9, 2005, Pages 553-557

  Jamora, R D G ^a   Gupta, A ^a   Tan, A K Y ^a   Tan, Louis C S ^a  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

Author keywords

Autonomic dysfunction; Cerebellar diseases; Orthostatic hypotension; Parkinsonism; Urinary incontinence

Indexed keywords

ADULT; AGED; AUTONOMIC NERVOUS SYSTEM; CEREBELLUM; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; CONSENSUS; DATA BASE; DISEASE COURSE; HUMAN; INDIAN; INFORMATION PROCESSING; MALAYSIA; MEDICAL RECORD; MOTOR DYSFUNCTION; NEUROIMAGING; ONSET AGE; PARKINSONISM; REVIEW; SHY DRAGER SYNDROME; SINGAPORE; WALKING AID; WHEELCHAIR;

EID: 29144514428     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28-34.
2. Quinn N. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry 1989;52(suppl):78-89.
3. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-8.
4. Lantos PL. Multiple system atrophy. Brain Pathol 1997;7:1293-7.
5. Wenning GK, Ben-Shlomo Y, Magalhães M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994;117:835-45.
6. Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996;46:1470.
7. Testa D, Filippini G, Farinotti M, Palazzini E, Caraceni T. Survival in multiple system atrophy: a study of prognostic factors in 59 cases. J Neurol 1996;243:401-4.
8. Ben-Shlomo Y, Wenning GK, Tison F, Quinn NP. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology 1997;48:384-93.
9. Schulz JB, Klockgether T, Petersen D, Jauch M, Muller-Schauenburg W, Spieker S, et al. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry 1994;57:1047-56.
10. Klockgether T, Lüdtke R, Kramer M, Abele M, Burk K, Schols L, et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain 1998;121:589-600.
11. Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E, et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002;125:1070-83.
12. World Health Organization. World Health Statistics Annual 1996. Geneva: Office of Publications, 1998:A6-A8.
13. Ministry of Health homepage. Singapore: Ministry of Health; c2004 [updated 2004 July]. Health Facts Singapore 2004. Available at: http://www.moh.gov.sg/corp/publications/statistics/population.do. Accessed 21 April 2005.
14. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125:861-70.
15. Osaki Y, Wenning GK, Daniel SE, Hughes A, Lees AJ, Mathias CJ, et al. Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 2002;59:1486-91.
16. Trenkwalder C, Schwarz J, Gebhard J, Ruland D, Trenkwalder P, Hense HW, et al. Starnberg trial on epidemiology of parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch Neurol 1995;52:1017-22.
17. Wenning GK, Tison F, Ben-Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-47.
18. Chrysostome V, Tison F, Yekhlef F, Sourgen C, Baldi I, Dartigues JF; MSA-Aquitaine Network. Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France. Neuroepidemiology 2004;23:201-8.
19. Vanacore N, Bonifati V, Fabbrini G, Colosimo C, De Michele G, Marconi R, et al; European Study Group on Atypical Parkinsonism (ESGAP). Epidemiology of multiple system atrophy. Neurol Sci 2001;22:97-9.
20. Kaufmann H. Multiple system atrophy. Curr Opin Neurol 1998;11: 351-5.
21. Sakakibara R, Hattori T, Uchiyama T, Kita K, Asahima M, Suzuki A, et al. Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation? J Neurol Neurosurg Psychiatry 2000;68:65-9.
22. Schrag A, Good CD, Miszkiel K, Morris HR, Mathias CJ, Lees AJ, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2002;54:697-702.
23. Schrag A, Kingsley D, Phatouros C, Mathias CJ, Lees AJ, Daniel SE, et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998;65:65-71.
24. Sandroni P, Ahlskog JE, Fealey RD, Low PA. Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res 1991;1: 147-55.
25. Riley DE, Chelimsky TC. Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease. J Neurol Neurosurg Psychiatry 2003;74:56-60.